Spencer C. Fleischer - Sep 30, 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Sep 30, 2021
Transactions value $
$30,638
Form type
4
Date filed
10/4/2021, 05:45 PM
Previous filing
Sep 2, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $30.6K +185 +19.6% $165.61 1.13K Sep 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +65.8 +0.69% $0.00 9.63K Aug 13, 2021 Common Stock 65.8 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of quarterly director's fee.
F2 1-for-1
F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.